Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|February 10, 2023
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patientsDevayani Machiraju, Jessica C Hassel
Life (Basel, Switzerland)|December 24, 2021
Potential Reasons for Unresponsiveness to Anti-PD1 Immunotherapy in Young Patients with Advanced MelanomaDevayani Machiraju, Sarah Schäfer, Jessica C Hassel
Cancers|March 10, 2022
TCR-Directed Therapy in the Treatment of Metastatic Uveal MelanomaSophia B Strobel, Devayani Machiraju, Jessica C Hassel
Cancers|April 13, 2024
Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma PatientsFouad Mitri, Devayani Machiraju, Christina Naoum, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2021
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatmentSophia B Strobel, Devayani Machiraju, Katharina A Kälber, et al.
Frontiers in Medicine|February 9, 2023
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanomaDevayani Machiraju, Sarah Schäfer, Philip Beckhove, et al.
Melanoma Research|February 28, 2018
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-αDevayani Machiraju, Iris Moll, Christoffer Gebhardt, et al.
Scientific Reports|March 4, 2018
Computationally-Guided Development of a Stromal Inflammation Histologic Biomarker in Lung Squamous Cell CarcinomaDaniel Xia, Ruben Casanova, Devayani Machiraju, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patientsSophia B Strobel, Devayani Machiraju, Melanie Wiecken, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2025
Artificial intelligence-assisted assessment of metabolic response to tebentafusp in metastatic uveal melanoma: a long axial field-of-view [<sup>18</sup>F]FDG PET/CT studyChristos Sachpekidis, Devayani Machiraju, Dimitrios Stefanos Strauss, et al.
Pageof 2